Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...

Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...

Advances in cloning and stem cell technology may soon enable custom-grown organs and longer lifespans. Secret Service finds ...

Oct 6 (Reuters) - AstraZeneca (AZN.L), opens new tab has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The ...

In an exciting scientific first, researchers at the Allen Institute successfully designed a new gene therapy that reversed symptoms related to SYNGAP1-related disorders (SRD) in mice. These are a ...

Infection of genital epithelial cells with human papillomavirus (HPV) types 16 and 18 is closely associated with the development of cervical carcinoma. The transforming potential of these high-risk ...

For decades, synthetic biologists have been developing gene circuits that can be transferred into cells for applications such as reprogramming a stem cell into a neuron or generating a protein that ...

In a video shared on the social media platform X on Thursday, the investor shared his thoughts on the probe into Tesla. "I don't think that they're [NHTSA] going after Tesla per se," the investor said ...

GRAND HAVEN, MI -- The remains of a West Michigan native killed in the Pacific Theater during World War II have been identified using DNA and other technology. Staff with the Defense POW/MIA ...

Gene Munster, Deepwater Asset Management managing partner, joins 'The Exchange' to discuss why equity markets aren't in a bubble, the OpenAI-Broadcom deal and much more. Donald Trump says Republican ...

Oct 6 (Reuters) - Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca (AZN.L), opens new tab a license to develop therapies the U.S.-based biotech discover using its AI-driven gene ...